Exact Mass: 1242.5350622
Exact Mass Matches: 1242.5350622
Found 16 metabolites which its exact mass value is equals to given mass value 1242.5350622
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
otophylloside H|qingyangshengenin 3-O-beta-D-glucopyranosyl-(1->4)-beta-D-glucopyranosyl-(1->4)-beta-D-cymaropyranosyl-(1->4)-beta-D-oleandropyranosyl-(1->4)-beta-D-digitoxopyranoside
C60H90O27 (1242.5669189999999)
6alpha-({O-beta-D-Fucopyranosyl-(1-->2)-O-beta-D-chinovopyranosyl-(1-->4)-O-[beta-D-chinovopyranosyl-(1-->2)]-O-beta-D-chinovopyranosyl-(1-->3)-beta-D-glucopyranosyl}oxy)-3beta-(sulfooxy)-5alpha-cholest-9(11)-en-23-on-monoammoniumsalz|6alpha-<(O-beta-D-Fucopyranosyl-(1-->2)-O-beta-D-chinovopyranosyl-(1-->4)-O-2)>-O-beta-D-chinovopyranosyl-(1-->3)-beta-D-glucopyranosyl)oxy>-3beta-(sulfooxy)-5alpha-cholest-9(11)-en-23-on-monoammoniumsalz
atracurium besylate
C65H82N2O18S2 (1242.5003792000002)
D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant Atracurium (BW-33A) besylate is a potent, competitive and non-depolarizing neuromuscular blocking agent. Atracurium besylate also is an AChR receptor antagonist. Atracurium besylate induces bronchoconstriction and neuromuscular blockade. Atracurium besylate promotes astroglial differentiation[1][2][3][4][5].
Cisatracurium Besylate
C65H82N2O18S2 (1242.5003792000002)
D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C66886 - Nicotinic Antagonist Cisatracurium besylate (51W89) is a nondepolarizing neuromuscular blocking agent, antagonizing the action of acetylcholine by inhibiting neuromuscular transmission.
[(1r,3as,3bs,5s,5as,7s,9as,11ar)-5-{[(2r,3r,4s,5r,6r)-4-{[(2s,3r,4s,5s,6r)-5-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-methyl-3-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-4-hydroxy-6-methyl-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-9a,11a-dimethyl-1-[(2r)-6-methyl-4-oxoheptan-2-yl]-1h,2h,3h,3ah,3bh,4h,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-7-yl]oxidanesulfonic acid
3-hydroxy-n-[(3r,4r,7s,20s,27r,28r,31s,44s)-6,19,30,43-tetrahydroxy-27-(3-hydroxyquinoline-2-amido)-4,15,28,39-tetramethyl-2,13,16,26,37,40-hexaoxo-1,5,12,15,18,25,29,36,39,42-decaazapentacyclo[42.4.0.0⁷,¹².0²⁰,²⁵.0³¹,³⁶]octatetraconta-5,18,29,42-tetraen-3-yl]quinoline-2-carboxamide
3-hydroxy-n-[(3r,4s,7s,20s,27r,28s,31s,44r)-6,19,30,43-tetrahydroxy-27-(3-hydroxyquinoline-2-amido)-4,15,28,39-tetramethyl-2,13,16,26,37,40-hexaoxo-1,5,12,15,18,25,29,36,39,42-decaazapentacyclo[42.4.0.0⁷,¹².0²⁰,²⁵.0³¹,³⁶]octatetraconta-5,18,29,42-tetraen-3-yl]quinoline-2-carboxamide
[5-({4-[(5-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl]oxy}-4-hydroxy-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl)oxy]-3,5-dihydroxy-6-methyloxan-2-yl}oxy)-1-(2-hydroxy-6-methyl-4-oxohept-5-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-7-yl]oxidanesulfonic acid
C56H90O28S (1242.5339060000001)